Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Focus on quetiapine.

B Green1

  • 1University of Liverpool, UK.

Current Medical Research and Opinion
|January 6, 2000
PubMed
Summary
This summary is machine-generated.

Quetiapine fumarate, an antipsychotic, effectively treats schizophrenia symptoms with a favorable side-effect profile. It shows efficacy comparable to haloperidol and superior to placebo, with minimal extrapyramidal symptoms.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Post-traumatic stress disorder cases reported by UK occupational physicians 1996-2024.

Occupational medicine (Oxford, England)·2026
Same author

Spinal Epidural Abscess Without Fever: Challenging the Classic Triad.

Irish medical journal·2024
Same author

Comparison of the survival of different isolates of SARS-CoV-2 in evaporating aerosols.

Aerosol science and technology : the journal of the American Association for Aerosol Research·2023
Same author

Pulse- and field-resolved THz-diagnostics at 4 <sup></sup> generation lightsources.

Optics express·2019
Same author

Clinical relevance of non-tuberculous mycobacteria isolated from respiratory specimens: seven year experience in a UK hospital.

Scientific reports·2019
Same author

On-chip THz spectrometer for bunch compression fingerprinting at fourth-generation light sources.

Journal of synchrotron radiation·2018
Same journal

Multidrug-resistant <i>Pseudomonas aeruginosa</i> in Jordan: epidemiology, trends, determinants, and clinical outcomes.

Current medical research and opinion·2026
Same journal

RSV disease and vaccination knowledge, attitudes, and practices among US adults: a 2024-2025 RSV season survey.

Current medical research and opinion·2026
Same journal

Clinical and healthcare resource utilization outcomes following revision knee arthroplasty with and without a gradually reducing radius revision knee system.

Current medical research and opinion·2026
Same journal

Medication adherence measurement methods and their reported relationship with medication safety outcomes: a scoping review.

Current medical research and opinion·2026
Same journal

BMI response to dapagliflozin with or without semaglutide across obesity classes: a real-world observational study conducted in Saudi Arabia.

Current medical research and opinion·2026
Same journal

Comparative efficacy of tislelizumab + FOLFOX or CAPOX for gastric/gastroesophageal junction adenocarcinoma: an exploratory matching-adjusted indirect comparison.

Current medical research and opinion·2026
See all related articles

Area of Science:

  • Pharmacology
  • Psychiatry

Background:

  • Quetiapine fumarate, marketed as Seroquel, is a novel dibenzothiazepine antipsychotic.
  • Initial research aimed for antipsychotic potential without clozapine's hematological toxicity.

Purpose of the Study:

  • To evaluate the clinical efficacy and tolerability of quetiapine in schizophrenia treatment.
  • To compare quetiapine's effectiveness against placebo and haloperidol.

Main Methods:

  • Dosage titration from 25 mg twice daily to 300 mg/day by day 4, with a typical effective range of 300-450 mg/day.
  • Assessment of efficacy in reducing positive and negative symptoms of schizophrenia.
  • Monitoring for adverse events, including somnolence and extrapyramidal symptoms.

Main Results:

Related Experiment Videos

  • Quetiapine is superior to placebo and comparable to haloperidol in reducing positive symptoms (150-750 mg/day).
  • Effective treatment for negative symptoms of schizophrenia.
  • Somnolence is the most common adverse event; rare QT interval abnormalities; no need for routine ECG, blood pressure, or hematological monitoring.

Conclusions:

  • Quetiapine demonstrates significant efficacy and a favorable side-effect profile for schizophrenia management.
  • Minimal extrapyramidal symptoms compared to placebo.
  • Quetiapine is a promising option for initial and long-term schizophrenia treatment.